Gene Set Enrichment Analysis Identifies Key Innate Immune Pathways in Primary Graft Dysfunction After Lung Transplantation

We hypothesized alterations in gene expression could identify important pathways involved in transplant lung injury. Broncho alveolar lavage fluid (BALF) was sampled from donors prior to procurement and in recipients within an hour of reperfusion as part of the NIAID Clinical Trials in Organ Transplantation Study. Twenty‐three patients with Grade 3 primary graft dysfunction (PGD) were frequency matched with controls based on donor age and recipient diagnosis. RNA was analyzed using the Human Gene 1.0 ST array. Normalized mRNA expression was transformed and differences between donor and postreperfusion values were ranked then tested using Gene Set Enrichment Analysis. Three‐hundred sixty‐two gene sets were upregulated, with eight meeting significance (familywise‐error rate, FWER p‐value <0.05), including the NOD‐like receptor inflammasome (NLR; p < 0.001), toll‐like receptors (TLR; p < 0.001), IL‐1 receptor (p = 0.001), myeloid differentiation primary response gene 88 (p = 0.001), NFkB activation by nontypeable Haemophilus influenzae (p = 0.001), TLR4 (p = 0.008) and TLR 9 (p = 0.018). The top five ranked individual transcripts from these pathways based on rank metric score are predominantly present in the NLR and TLR pathways, including IL1β (1.162), NLRP3 (1.135), IL1α (0.952), IL6 (0.931) and CCL4 (0.842). Gene set enrichment analyses implicate inflammasome–mediated and innate immune signaling pathways as key mediators of the development of PGD in lung transplant patients.

[1]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[2]  S. Keshavjee,et al.  Ischemia-reperfusion-induced lung injury. , 2003, American journal of respiratory and critical care medicine.

[3]  T. Shoji,et al.  OPTIMAL ALVEOLAR OXYGEN CONCENTRATION FOR COLD STORAGE OF THE LUNG1 , 2001, Transplantation.

[4]  J. Pittet,et al.  Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade , 2007, Thorax.

[5]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Voehringer,et al.  Disease-specific gene expression profiling in multiple models of lung disease. , 2008, American journal of respiratory and critical care medicine.

[7]  J. Dark,et al.  Lung preservation: a review of current practice and future directions. , 1993, The Annals of thoracic surgery.

[8]  L. Ware.  Pathophysiology of acute lung injury and the acute respiratory distress syndrome. , 2006, Seminars in respiratory and critical care medicine.

[9]  J. Orens,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  Shaf Keshavjee,et al.  Primary Graft Dysfunction: Definition, Risk Factors, Short- and Long-Term Outcomes , 2010, Seminars in respiratory and critical care medicine.

[11]  H. Shennib,et al.  Early cellular events in the lung allograft. , 1992, The Annals of thoracic surgery.

[12]  H. Rozycki,et al.  Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. , 1995, Experimental lung research.

[13]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[14]  L. O’Neill,et al.  Biochemical regulation of the inflammasome , 2012, Critical reviews in biochemistry and molecular biology.

[15]  Shizuka Uchida,et al.  Gene Array Analyzer: alternative usage of gene arrays to study alternative splicing events , 2011, Nucleic acids research.

[16]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[17]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[18]  S. Ryter,et al.  Inflammasome-regulated cytokines are critical mediators of acute lung injury. , 2012, American journal of respiratory and critical care medicine.

[19]  A. Localio,et al.  Construct validity of the definition of primary graft dysfunction after lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  V. Dixit,et al.  Modulation of Inflammasome Pathways by Bacterial and Viral Pathogens , 2011, The Journal of Immunology.

[21]  Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. , 1990, The American review of respiratory disease.

[22]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Campbell,et al.  Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. , 1989, The American review of respiratory disease.

[24]  G. Patterson,et al.  Lung Transplantation: Current Status and Future Prospects , 1999, World Journal of Surgery.

[25]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  H. Hakonarson,et al.  IL1RN Polymorphism Is Associated With Lower Risk Of Acute Lung Injury In Two Separate At-Risk Populations , 2010, ATS 2010.

[27]  S. Kimmel,et al.  Clinical risk factors for primary graft failure following lung transplantation. , 2003, Chest.

[28]  G. Patterson,et al.  Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. , 2007, American journal of respiratory and critical care medicine.

[29]  S. Der,et al.  Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. , 2006, The Journal of Heart and Lung Transplantation.

[30]  U. Rauen,et al.  Mammalian Cell Injury Induced by Hypothermia the Emerging Role for Reactive Oxygen Species , 2002, Biological chemistry.

[31]  F. Sutterwala,et al.  Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.

[32]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[33]  T. Egan,et al.  Lung transplantation: opportunities for research and clinical advancement. , 2005, American journal of respiratory and critical care medicine.

[34]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.